Hamlin PJ - Search Results

1

Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.

Thanaraj S, Hamlin PJ, Ford AC. Thanaraj S, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2010 Dec;32(11-12):1297-306. doi: 10.1111/j.1365-2036.2010.04490.x. Epub 2010 Oct 14. Aliment Pharmacol Ther. 2010. PMID: 21050231 Free article. Review.

2

Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature.

Hamlin PJ, Shah MN, Scott N, Wyatt JI, Howdle PD. Hamlin PJ, et al. Postgrad Med J. 2004 Apr;80(942):233-5. doi: 10.1136/pgmj.2003.007385. Postgrad Med J. 2004. PMID: 15082847 Free PMC article. Review.

3

Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ. Palaniappan S, et al. Among authors: hamlin pj. Inflamm Bowel Dis. 2007 Dec;13(12):1488-92. doi: 10.1002/ibd.20258. Inflamm Bowel Dis. 2007. PMID: 17924566

4

Anti-tumour necrosis factor-alpha therapies in Crohn's disease.

Sprakes MB, Hamlin PJ. Sprakes MB, et al. Among authors: hamlin pj. Br J Hosp Med (Lond). 2009 Nov;70(11):644-7. doi: 10.12968/hmed.2009.70.11.45055. Br J Hosp Med (Lond). 2009. PMID: 20081592 Review.

5

Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated?

Thanaraj S, Hamlin PJ, Ford AC. Thanaraj S, et al. Among authors: hamlin pj. Dig Dis Sci. 2010 Jun;55(6):1803; author reply 1803-4. doi: 10.1007/s10620-010-1188-3. Dig Dis Sci. 2010. PMID: 20431950 No abstract available.

6

Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.

Halpin SJ, Hamlin PJ, Ford AC. Halpin SJ, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2010 Nov;32(10):1294-5. doi: 10.1111/j.1365-2036.2010.04478.x. Aliment Pharmacol Ther. 2010. PMID: 20955450 Free article. No abstract available.

7

Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.

Sprakes MB, Ford AC, Suares NC, Warren L, Greer D, Donnellan CF, Jennings JS, Everett SM, Hamlin PJ. Sprakes MB, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2010 Dec;32(11-12):1357-63. doi: 10.1111/j.1365-2036.2010.04482.x. Epub 2010 Oct 7. Aliment Pharmacol Ther. 2010. PMID: 21050238 Free article.

8

Effect of oral zinc in hepatic encephalopathy remains unclear.

Coughlan J, Hamlin PJ, Ford AC. Coughlan J, et al. Among authors: hamlin pj. Aliment Pharmacol Ther. 2010 Dec;32(11-12):1405-6; author reply 1406-7. doi: 10.1111/j.1365-2036.2010.04483.x. Aliment Pharmacol Ther. 2010. PMID: 21050244 Free article. No abstract available.

9

Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.

Sprakes MB, Hamlin PJ, Warren L, Greer D, Ford AC. Sprakes MB, et al. Among authors: hamlin pj. J Crohns Colitis. 2011 Aug;5(4):324-31. doi: 10.1016/j.crohns.2011.02.007. Epub 2011 Mar 10. J Crohns Colitis. 2011. PMID: 21683302 Clinical Trial.

10

Infliximab and surgical treatment of complex anal Crohn's disease.

Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ. Duff S, et al. Among authors: hamlin pj. Colorectal Dis. 2012 Aug;14(8):972-6. doi: 10.1111/j.1463-1318.2011.02811.x. Colorectal Dis. 2012. PMID: 21899707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results